Jaguar Health Q2 EPS $(4.04) Misses $(1.11) Estimate, Sales $2.72M Miss $3.94M Estimate
Portfolio Pulse from Benzinga Newsdesk
Jaguar Health (NASDAQ:JAGX) reported Q2 earnings per share (EPS) of $(4.04), significantly missing the analyst estimate of $(1.11). The company also reported sales of $2.72 million, falling short of the $3.94 million estimate.
August 13, 2024 | 12:44 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Jaguar Health reported a significant miss on both EPS and sales for Q2, with EPS at $(4.04) compared to the $(1.11) estimate and sales at $2.72 million versus the $3.94 million estimate.
The significant miss on both EPS and sales is likely to negatively impact the stock price in the short term. The EPS miss by 263.96% and sales miss by 30.93% indicate poor financial performance, which is likely to concern investors.
CONFIDENCE 100
IMPORTANCE 90
RELEVANCE 100